Hepatitis B antibodies
US12331104B2 · kind B2 · utility
0Cited by
39References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2024 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Feb 6, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-HBsAg antibodies, antibody fragments, and their uses for the prevention and treatment of hepatitis B virus infection and associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.